Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort

BACKGROUND: Despite widespread use in HIV and hepatitis B virus (HBV) infection, the effectiveness of tenofovir (TDF) has not been studied extensively outside of small HBV-HIV coinfected cohorts. We examined the effect of prior lamivudine treatment (3TC) and other factors on HBV DNA suppression with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kim, H. Nina, Rodriguez, Carla V., Van Rompaey, Stephen, Eron, Joseph J., Thio, Chloe L., Crane, Heidi M., Overton, Edgar T., Saag, Michael S., Martin, Jeffrey, Geng, Elvin, Mugavero, Michael, Rodriguez, Benigno, Mathews, W. Christopher, Boswell, Stephen, Moore, Richard, Kitahata, Mari M.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981874/
https://ncbi.nlm.nih.gov/pubmed/24500175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000126
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares